Safety and Efficacy Study of TAR-0520 Gel in Prevention of Taxane-induced Peripheral Neuropathy
NCT07082764
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Chemotherapy Induced Peripheral Neuropathy
Interventions
DRUG:
Brimonidine gel
OTHER:
No intervantion
Sponsor
Tarian Pharma